位置:首页 > 蛋白库 > PRLS_FUNXX
PRLS_FUNXX
ID   PRLS_FUNXX              Reviewed;        4037 AA.
AC   A0A089FSA4;
DT   30-AUG-2017, integrated into UniProtKB/Swiss-Prot.
DT   26-NOV-2014, sequence version 1.
DT   03-AUG-2022, entry version 35.
DE   RecName: Full=Hybrid PKS-NRPS synthetase prlS {ECO:0000303|PubMed:25226362};
DE            EC=2.3.1.- {ECO:0000305|PubMed:25226362};
DE            EC=6.3.2.- {ECO:0000305|PubMed:25226362};
DE   AltName: Full=Pyrrolocin biosynthesis protein S {ECO:0000303|PubMed:25226362};
GN   Name=prlS {ECO:0000303|PubMed:25226362};
OS   Fungal sp. (strain NRRL 50135).
OC   Eukaryota; Fungi.
OX   NCBI_TaxID=1547289;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND PATHWAY.
RX   PubMed=25226362; DOI=10.1021/sb500296p;
RA   Kakule T.B., Jadulco R.C., Koch M., Janso J.E., Barrows L.R., Schmidt E.W.;
RT   "Native promoter strategy for high-yielding synthesis and engineering of
RT   fungal secondary metabolites.";
RL   ACS Synth. Biol. 4:625-633(2015).
RN   [2]
RP   FUNCTION.
RX   PubMed=25351193; DOI=10.1021/np500617u;
RA   Jadulco R.C., Koch M., Kakule T.B., Schmidt E.W., Orendt A., He H.,
RA   Janso J.E., Carter G.T., Larson E.C., Pond C., Matainaho T.K.,
RA   Barrows L.R.;
RT   "Isolation of pyrrolocins A-C: cis- and trans-decalin tetramic acid
RT   antibiotics from an endophytic fungal-derived pathway.";
RL   J. Nat. Prod. 77:2537-2544(2014).
CC   -!- FUNCTION: Hybrid PKS-NRPS synthetase; part of the gene cluster that
CC       mediates the biosynthesis of pyrrolocin, a bright yellow trans-fused
CC       decalin-containing tetramic acid with antimicrobial activity
CC       (PubMed:25226362, PubMed:25351193). The PKS module of prlS together
CC       with the enoylreductase prlC catalyze the formation of the polyketide
CC       unit which is then conjugated to L-serine by the condensation domain of
CC       the prlS NRPS module (PubMed:25226362). Diels-Alderase gNR600 is
CC       involved in endo-selective Diels-Alder cycloaddition to form the
CC       decalin ring (By similarity). Subsequent methylation is carried leads
CC       to pyrrolocin A (PubMed:25226362). The methyltransferase involved in
CC       that last step has not been identified yet and is probably located
CC       outside of the prl cluster (PubMed:25226362).
CC       {ECO:0000250|UniProtKB:A0A0E4AZP0, ECO:0000269|PubMed:25226362,
CC       ECO:0000269|PubMed:25351193}.
CC   -!- PATHWAY: Mycotoxin biosynthesis. {ECO:0000269|PubMed:25226362}.
CC   -!- DOMAIN: NRP synthetases are composed of discrete domains (adenylation
CC       (A), thiolation (T) or peptidyl carrier protein (PCP) and condensation
CC       (C) domains) which when grouped together are referred to as a single
CC       module. Each module is responsible for the recognition (via the A
CC       domain) and incorporation of a single amino acid into the growing
CC       peptide product (By similarity). Thus, an NRP synthetase is generally
CC       composed of one or more modules and can terminate in a thioesterase
CC       domain (TE) that releases the newly synthesized peptide from the enzyme
CC       (By similarity). Occasionally, epimerase (E) domains (responsible for
CC       l- to d-amino acid conversion) are present within the NRP synthetase
CC       (By similarity). PrlS contains also a polyketide synthase module (PKS)
CC       consisting of several catalytic domains including a ketoacyl synthase
CC       domain (KS), an acyl transferase domain (AT), a dehydratase domain
CC       (DH), a methyltransferase domain (MT), and a ketoreductase domain (KR)
CC       (By similarity). Instead of a thioesterase domain (TE), prlS finishes
CC       with a reductase-like domain (R) for peptide release (By similarity).
CC       PrlS has the following architecture: KS-AT-DH-KR-PCP-C-A-T-R (By
CC       similarity). {ECO:0000250|UniProtKB:Q4WAZ9, ECO:0000255}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the NRP synthetase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KM107910; AIP87510.1; -; Genomic_DNA.
DR   SMR; A0A089FSA4; -.
DR   GO; GO:0004315; F:3-oxoacyl-[acyl-carrier-protein] synthase activity; IEA:InterPro.
DR   GO; GO:0016874; F:ligase activity; IEA:UniProtKB-KW.
DR   GO; GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW.
DR   GO; GO:0031177; F:phosphopantetheine binding; IEA:InterPro.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IEA:InterPro.
DR   GO; GO:0032259; P:methylation; IEA:UniProtKB-KW.
DR   GO; GO:0044550; P:secondary metabolite biosynthetic process; IEA:UniProt.
DR   Gene3D; 1.10.1200.10; -; 2.
DR   Gene3D; 3.10.129.110; -; 1.
DR   Gene3D; 3.30.300.30; -; 1.
DR   Gene3D; 3.30.559.10; -; 1.
DR   Gene3D; 3.40.366.10; -; 1.
DR   Gene3D; 3.40.47.10; -; 1.
DR   Gene3D; 3.40.50.12780; -; 1.
DR   Gene3D; 3.40.50.150; -; 1.
DR   InterPro; IPR001227; Ac_transferase_dom_sf.
DR   InterPro; IPR036736; ACP-like_sf.
DR   InterPro; IPR014043; Acyl_transferase.
DR   InterPro; IPR016035; Acyl_Trfase/lysoPLipase.
DR   InterPro; IPR045851; AMP-bd_C_sf.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   InterPro; IPR042099; ANL_N_sf.
DR   InterPro; IPR023213; CAT-like_dom_sf.
DR   InterPro; IPR001242; Condensatn.
DR   InterPro; IPR013120; Far_NAD-bd.
DR   InterPro; IPR018201; Ketoacyl_synth_AS.
DR   InterPro; IPR014031; Ketoacyl_synth_C.
DR   InterPro; IPR014030; Ketoacyl_synth_N.
DR   InterPro; IPR016036; Malonyl_transacylase_ACP-bd.
DR   InterPro; IPR013217; Methyltransf_12.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR032821; PKS_assoc.
DR   InterPro; IPR020841; PKS_Beta-ketoAc_synthase_dom.
DR   InterPro; IPR020807; PKS_dehydratase.
DR   InterPro; IPR042104; PKS_dehydratase_sf.
DR   InterPro; IPR013968; PKS_KR.
DR   InterPro; IPR020806; PKS_PP-bd.
DR   InterPro; IPR009081; PP-bd_ACP.
DR   InterPro; IPR029063; SAM-dependent_MTases_sf.
DR   InterPro; IPR016039; Thiolase-like.
DR   Pfam; PF00698; Acyl_transf_1; 1.
DR   Pfam; PF00501; AMP-binding; 1.
DR   Pfam; PF00668; Condensation; 1.
DR   Pfam; PF16197; KAsynt_C_assoc; 1.
DR   Pfam; PF00109; ketoacyl-synt; 1.
DR   Pfam; PF02801; Ketoacyl-synt_C; 1.
DR   Pfam; PF08659; KR; 1.
DR   Pfam; PF08242; Methyltransf_12; 1.
DR   Pfam; PF07993; NAD_binding_4; 1.
DR   Pfam; PF00550; PP-binding; 2.
DR   Pfam; PF14765; PS-DH; 1.
DR   SMART; SM00827; PKS_AT; 1.
DR   SMART; SM00826; PKS_DH; 1.
DR   SMART; SM00825; PKS_KS; 1.
DR   SMART; SM00823; PKS_PP; 2.
DR   SUPFAM; SSF47336; SSF47336; 2.
DR   SUPFAM; SSF51735; SSF51735; 3.
DR   SUPFAM; SSF52151; SSF52151; 1.
DR   SUPFAM; SSF53335; SSF53335; 1.
DR   SUPFAM; SSF53901; SSF53901; 1.
DR   SUPFAM; SSF55048; SSF55048; 1.
DR   PROSITE; PS00455; AMP_BINDING; 1.
DR   PROSITE; PS00606; B_KETOACYL_SYNTHASE; 1.
DR   PROSITE; PS50075; CARRIER; 2.
PE   3: Inferred from homology;
KW   Ligase; Methyltransferase; Multifunctional enzyme; Oxidoreductase;
KW   Phosphopantetheine; Phosphoprotein; Repeat; Transferase.
FT   CHAIN           1..4037
FT                   /note="Hybrid PKS-NRPS synthetase prlS"
FT                   /id="PRO_0000441291"
FT   DOMAIN          2447..2522
FT                   /note="Carrier 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          3610..3687
FT                   /note="Carrier 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   REGION          7..445
FT                   /note="Ketosynthase (KS) domain"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:25226362"
FT   REGION          557..879
FT                   /note="Malonyl-CoA:ACP transacylase (MAT) domain"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:25226362"
FT   REGION          950..1251
FT                   /note="Dehydratase (DH) domain"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:25226362"
FT   REGION          1448..1610
FT                   /note="Methyltransferase (MT) domain"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:25226362"
FT   REGION          2144..2315
FT                   /note="Ketoreductase (KR) domain"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:25226362"
FT   REGION          2535..2594
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2614..3046
FT                   /note="Condensation (C) domain"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:25226362"
FT   REGION          3094..3495
FT                   /note="Adenylation (A) (KR) domain"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:25226362"
FT   REGION          3724..3961
FT                   /note="Reductase (RED) domain"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:25226362"
FT   REGION          3894..3915
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2556..2586
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        178
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10022"
FT   MOD_RES         2482
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         3647
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
SQ   SEQUENCE   4037 AA;  442186 MW;  E1E3CAB6E99C85F0 CRC64;
     MSSTEPIAVI GSACRFPGSS DRPSKLWELL REPRDLLQKV SERRRWHPDA FYHSDPEHHG
     TTNVRSSYFL DEDPADFDNA FFNIQPSEAE AIDPQQRMLM ETVYDSLCSA GQTIEGLRGS
     STAVIVGTMC DDWSGVLYKD WETIPQYSAT GMGRSIMSNR VSYFFDWHGP SMTLDTACSS
     SLVAVHLAIQ ALRTGESRVA VAAGANLLLG PGMYIAEANL HMLSPKGRSA MWDKDVDGYA
     RGEGIASVIL KPLSAAIEDG DHIECLIRAT GVNQDGRTQG LTMPSATAQA ALIRETYARA
     GLDIDKPEDR PQFFHAHGTG TPAGDPQEAE AISKAFYSQD ASDSLYVGSI KTVIGHTEGT
     AGLASLLGTS LALQHGMVPP NMHFNELNPR IAPFYGNLQV PTTAKPWPKL LPGQPRRASV
     NSFVFVIYLD SWLTWPPNAG FGGTNAHAIL EAYEPPSVSP SAGPLFSPLT ISAATEKSLR
     ALMSSYSEYL KANPKTSLRD FAYTLQERRS TLAFRAAIAA STSDEAAIKI DGLLDAEDAR
     ELSTKHFGIP SPRLLGVFTG QGAQWPRMGA RLVEASPFVA TRLDELDASL ASLPESIRPE
     WTLKEQMLED AATSRVAEAA VSQPLCTAVQ ILLVDLLSVA GVRFHAVVGH SSGEIGAAYA
     AGLLSASSAI RIAYLRGLYA KLANSPNGNI RGAMMAAGTS FEDASEFCQL EGFEGRIQVA
     AVNSASSITL SGDEDAIAEA VEIFKDEGKF ARQLKVDTAY HSAHMLPCSK PYLKSLEAMT
     DVLGADASGE GKPAWYSSVH EGEIMKPAAL NPQYWVSNMT NTVLFAPAVA AAVAQSGPFD
     MALELGPHPA LKGPCLDTLA EALGDRIPYS GLLSRGQDDI SEMSAALGSV WSNLGAGSVS
     FETFEKSISG DLKGRNLIAD LPKYEFDHSR SFWTISRAVG AQLVAHDPPH PVLGRRCVDR
     ETSREIQWRN ILSPKEVPWL KGHRIQGGIV YPAAGFVAMA VEAMRALAGK SSINLIKIDN
     LFIGRAIAFN EETSTVETLF SVKVVSSSDE SIQASFSCYS GAPHEPGTSM GLNAEGIVTV
     TLADHEADVI LFVEPKDFNM TEIETDRFYD QFQRLEYEYS PPFRGMLAIK RKKGHARGTI
     EDQSGSDWED QFLIHPGMLD TAFQSSSAAF SCPGDGMMWG LYIPAGIQSI VINPYFTPAG
     MGKQQTLPWE AIARSMHKAR STMDINIFSQ DSTHTFIQVE GLELMPFTAA RPEDDAVIFS
     RFDYKIDGPS GDIAVADDGF TAEALENAIK GERVSFYYLR RLVESITPEE KANAPRYYRH
     LLDWASHVVD RVKSGKNPFV QSSWQLDTEE QIKAIWDKYG DRVDVRLIES VGKHLPDVIR
     KGTSILEHME GLFEFYDQGL GLDMANRHLA RMVAQVGHRY PQMRVFEIGE PRKPAPMLLC
     CHSDSRVLGA GTGGSTRTIL SYLGDMFSSY TYTDISSGFF EAAQDRFKDF ESRMVYKTFD
     MERDPESQGF VEGSYDLVLA SNCLHATDKL EEMMTNARRL LRPGGYLIAL ELTSNETMRV
     GLPMGSLPGW WVGAESGRPW GPTVTLPQWD SLLRKCGFGG IDTSTPLLHK LHVSTVFAAQ
     AVDDRVSLLR SPLASITVLP PTDAPRLVVV GGEALATHRI AERVASLLGP RFSDIARVTS
     FESLDIDALP YGSTVLSLSE LDEPLFKNMN PAKLDALKTL WRQAGKILWV TRGARAEEPF
     SSMMLGLGRA MTHEYPNISL QILDLDRLED EEKTAQLFTA ELLRLEVLKK WQHEAQGEVD
     FLWSIEPEVC FEGGARLIPR LYKCRPANDR YNSARRPVMT EIDPRETPIL FASEGASYEL
     QHPSPLRIPS APPAVSKTRT VNVSHFLLQT VHMSSAGRFM LFAGADRYTG ERLLGLSHTT
     ESQPTVPTEW TFPIASEGTN PAEALSSVYG QIIAREILKM VPKGSSIVVH EPDPSLGAAL
     LQQAEACATE VVLTTSRKGS VSSEGRFIPA NLSRRLVKKA LPDSTSLYVD LSHAGESSEA
     GKLIGKCLPG SCSTYGSGYF HGTTPELRPG SSSSQLSAIF KAACEAAFEG QCQTAIPDIV
     QLQDVPSLRA IGRPLTVVDC VSTATVPVNV QTVDSGMIFR ADKTYFLVGM SGQVGQSLCQ
     WMVERGARYV VLTSRHPQVH PEYVKSMEAM GATIRVLPLD ITSRDSLQQC YAEMCKTMPP
     VAGVAQGAMV LRDSMFDGLS FENLTAVLDP KVTGTQLLDE LFYDAPLDFF IVMSSLTSVV
     GNSGQSNYTA ANMFMVALAE QRRKRGVAGS AIAISSLIGI GYVERSEDFT GDYFEKIGYR
     NISEQDLHQL FAEAILVGRP GCRESSEITT GLEPFYPERN AKAQFFDDIR FNHFILERHD
     AQNLGGKGSA VPVRVQLAEV KTRDEAAVII KGEANSRKND FETQKADSRT DGFLARLRRT
     LMISQDEAVN EKASLVEQGI DSLMAVEVRS WFLKELEVDI PVLKILGGSS ITDLLNEALE
     RVPVSVVDLK AMANTKASTP EHRKVSVPPP PSVEVKSSSP GSSSEPQSSP ADSPSRPSTP
     LRTPMTEMEE SKTLAPVVVE KPKVYPAAKE EASEMSYGQA RFWFLSGYLE DKTSFNMTVM
     FKLTGKLQVA RLESAVRTVA QRHEALRTRF FWSGEGDRRT PMQGVLSESP IQLEHVRIES
     EADAQKQLAK MHEYVWDLNS WEAARMVLLT VDDDVHYFMV SGHHISWDGY SFTVLFVDLD
     AAYCGRPLAP LGPECQYPAF AAWQRDTYAA GAMKKAIDTY YRPMIDPHAK AIPLFPFAKS
     PTRPLLDHFE QFEAKATLQP ALVSKLKQLS RKNGATMFHL YLAALQALVF RLLPEEDDFY
     LGVADANRMD KSFMGSLGFF LNLLPVRFDR SQPGTKISEI IKDTRNKAYK ALENSFVPWN
     VLLQELKIPR TNTEAPIFQL FVDYRQIARD RAQWCGCALS DEDWLNARNG YDLTLGITDN
     PTGESLLSLR FQKKLYSEHS TNLFLRSYVT VLESFATGVD LEVSELPRWA PSDVEATLEA
     GKVYRKLMTN PQGPCTQLDW PATVSHRIDE MIHEHTAQPA LKDGLGNSLT YGQMRDRINM
     ISAALIAGGA IEGSSIGVFQ NPSADWICSM LAIFRIGATY VPLDLRNSIA RIVSIVADVQ
     PTVILSDRYT TTKIRQIGAV QATEIVVSDI ATSVSAPDLP NKAAPDSRAV ILFTSGTTGK
     PKGVILTHAN LRAQCEGYSR MVDLPSMVSV VLQQTIYNFD VSLDQIFAAL ADGGCLYVVP
     AEKRGDPQAI TEIMAEQGVT YTVATPSEYE IWFRYARDNL ARCKSWGYAF GGGEHLHSGL
     IHEFSSLAAQ HIPGLRLFNN YGPTEASLAI TKGEVQHSDP GLEDHVPAGW IIPNYKVAVV
     DEKLQPVPFE TSGEILAGGP GVASGYLGQD ELTREKFIAG VRIHPLAAKS ANTWYRTGDR
     GRLRRDGALY VDGRILGDSQ VKIRGFRVEL QEIEAVLLEA AKGALSHAVI TARGTGEDRF
     LAAHVVFAPD FPQHRRQATI HHLESKLPLP PYMQPTVIVP LASIPVTSNF KLDRKAIQAL
     PLPETDGLGE NLADVEKSVA MLWKSIIPHG VRDLTPETNF FDVGGNSILL VKLKAAMSRE
     LKVTPLLIDL MNSSTLGGMA RIVRASSGAR VINWEAETSV PESLRALVKQ KKTLSRSKRK
     NENLVVVLAG ATGYLGRHIL ARLVNAPEVS EINCLVRDEG LEAATSSLQN SPKVRLIPAD
     LSQPDIGLSL AKFSDLSQRA DIVVDCAANR SFWDGYETLR TVNLDAVKEL ARLCVTNGAS
     LHFVSSGAVQ AYENSAPPTD GSDGYVASKW AAETFLRRAA ESLGLQVHIH RPLGSADVGA
     PDSTPDRKNP STKDEIQRDL DHILLKLGKR PDFSAVTGYV DVTPVNSVVS DMVAAMIQEI
     SSGHGGAMLR VTEHRGRLRL HIKEFGDHIG ASSQLSALPT MNPLFWFADA KKAGFAQLIT
     SQRLVMHNKE GELVTRR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024